Clinical Trials

Showing trials with last updates posted in 2023.

NCT04081389 | COMPLETED | PHASE1
9 participants

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-11
Start Date:
2019-12-06
Completion:
2022-05-24
Conditions
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Early-Stage Breast Carcinoma
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • Progesterone Receptor Negative
  • Prognostic Stage 0 Breast Cancer AJCC v8
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT03912818 | TERMINATED | PHASE2
7 participants

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-11
Start Date:
2019-04-10
Completion:
2022-08-11
Conditions
  • Bladder Adenocarcinoma
  • Bladder Mixed Adenocarcinoma
  • Bladder Squamous Cell Carcinoma
  • Bladder Urothelial Carcinoma
  • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
  • Infiltrating Bladder Urothelial Carcinoma With Giant Cells
  • Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
  • Infiltrating Bladder Urothelial Carcinoma With Trophoblastic Differentiation
  • Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant
  • Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant
  • Infiltrating Bladder Urothelial Carcinoma, Nested Variant
  • Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
NCT03057119 | COMPLETED | NA
86 participants

Feasibility of SBIRT-PN

Study Type:
INTERVENTIONAL
Last Updated:
2023-09-11
Start Date:
2018-02-12
Completion:
2021-02-28
Conditions
  • Substance Use
  • HIV/AIDS
  • Older Adults
  • Behavioral Intervention
  • Infectious Disease
Interventions
  • BEHAVIORAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page